logo
15:59 Feb 25

Laurus Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1076.35
+47.85 (+4.65%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Laurus Labs Ltd. Financials

Laurus Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1076.35
+47.85 (+4.65%)
15:59 Feb 25
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

33/100
Mid Valuation

Technical

66/100
Technically Moderately Bullish

Strength

13

Weakness

4

Opportunity

1

Threats

0

8.01 %

ROE %

3.83 %

ROA %

15.62

EPS

82.99

BVPS

6.45 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
4813.51 4935.57 6040.55 5040.83 5553.96
Operating Expenses +
3262.83 3513.14 4448.36 4263.33 4498.68
Raw Material
2455.2 2414.94 2752.28 2533.3 2533.91
Increase Decrease in Cost
-297.01 -221.17 22.04 -100.88 -55.93
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
434.09 501.53 580.64 639.93 719.52
Miscellaneous Expenses
863.01 1109.46 1404.82 1412.82 1511.9
Operating Profit
1550.68 1422.43 1592.19 777.5 1055.28
Other Income
23.66 13.58 6 26.34 59.93
Depreciation
205.07 251.49 324.08 384.58 430.09
Interest
68.16 100.67 165.17 182.9 200.83
Profit before tax and exceptio..
1301.11 1083.85 1108.94 236.36 484.29
Exceptional Items
0 0 0 0 0
PBT
1301.11 1083.85 1108.94 236.36 484.29
Provision for Taxation
317.29 251.42 312.3 68.15 129.88
Net Profit
983.82 832.43 796.64 168.21 354.41
NET Profit after MI
983.58 827.52 790.11 160.55 358.32
EPS
18.28 15.42 14.64 2.97 6.64
Operating Profit Margin (%)
32.22 28.82 26.36 15.42 19
Net Profit Margin (%)
20.43 16.77 13.08 3.19 6.45

Laurus Labs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 27.50 27.60 27.60 27.60 27.60 27.20
FII 26.50 26.20 25.70 25.50 25.60 26.10
Public 12.40 11.70 11.90 11.80 12.70 13.00
Others 33.60 34.50 34.80 35.10 34.10 33.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: